Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason - iShares Biotechnology ETF (NASDAQ:IBB), SPDR Select Sector Fund - Health Care (ARCA:XLV)

The Health Care Select Sector SPDR Fund XLV, heavily tilted towards mega-caps, lost around 5.25% over the last month, with substantial companies reporting annual earnings.
Shares of Health Care Select Sector SPDR Fund opened at $129.26 on Monday, with a twelve-month low of $118.75 and a twelve-month high of $143.42. YTD shares lost 6.54%.
Top holding companies Merck & Co Inc MRK, AbbVie Inc ABBV, Eli Lilly And Co LLY, Thermo Fisher Scientific Inc TMO, Abbott Laboratories ABT, and Bristol Meyers Squibb & Co BMY reported their Q4 earnings during the month.
Over the month, Lilly stock lost 5.5%, Thermo Fisher fell 2.45%, Abbott lost 6.54%, Bristol Myers slipped 7.2%, while Merck shares gained 6.28%, and AbbVie jumped 7.2%.
Over one month, iShares Biotechnology ETF IBB shares have fallen 4.3%, with stock opening at $130.27.
Today, Aclaris Therapeutics Inc ACRS was retreating nearly 40% after zunsemetinib did not meet its primary and secondary efficacy endpoints.
Adaptimmune Therapeutics Inc ADAP and TCR2 Therapeutics Inc TCRR agreed to merge.
TCR2 was rising over 25% in value, while Adaptimmune Therapeutics was down more than 20%.
BridgeBio Pharma Inc BBIO shares are gaining over 50% after positive data from the PROPEL2 Phase 2 trial of infigratinib in the form of dwarfism.
Price Action: XLV shares closed down 1.60% at $127.04, and IBB closed down 1.59% at $127.25 on Tuesday.